Supplements and Featured Publications, Biologics and Benefit Design, Volume 14, Issue 8 Suppl
This supplement to The American Journal of Managed Care discusses recent research and proprietary analytic tools employers can use to design a benefit plan that is fiscally responsible, yet does not saddle their sickest employees with burdensome out-of-pocket
expenses or restrict members’ access to essential therapies, such as biotechnology-derived treatments. This supplement also includes commentary from several industry leaders regarding their time-tested approaches to developing effective benefit strategies.
Robert D. Moroni (Moderator)
Barbara J. Hodge
Integrated Therapeutics Institute
Frank Kopenski, ASA, MAAA
Grant D. Lawless, MD, RPh
Kenneth D.Wells, MD
Vice President, Health Outcomes
Vice President, Employee
Raymond J. Brusca
Louise Probst, RN, MBA
St. Louis Area Business
Julie G.Tatum, GBA
Robert C.Wald
Director, Corporate Medical
Lynn Zonakis, BSN
Director, Health Strategy
Robert D. Moroni
Robert Berglund has nothing to disclose.
David Hom and Wayne M. Lednar, MD, PhD, have nothing to disclose.
This supplement has been supported by